The World Orphan Drug Congress is the largest and most established orphan drugs & rare diseases meeting of its kind across the globe.
Join our Director General, Dr. Claire Skentelbery on the 1st of November for her Keynote Panel: How to navigate the new legislation to enable orphan drug developers to stay innovative and profitable in Europe.
As well as on the 2nd on November for her Panel: How to enable SME’s to obtain greater market access.